Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Maneuvering Clinical Pathways for Ulcerative Colitis.

Johnson CM, Linzay CD, Dassopoulos T.

Curr Gastroenterol Rep. 2019 Sep 5;21(10):52. doi: 10.1007/s11894-019-0716-3. Review.

PMID:
31486929
2.

Clinical, Histologic, and Immunophenotypic Features of Serrated Polyps in Patients With Inflammatory Bowel Disease.

Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu I.

Gastroenterology Res. 2018 Oct;11(5):355-360. doi: 10.14740/gr1064w. Epub 2018 Oct 1.

3.

Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.

Reinisch W, Bressler B, Curtis R, Parikh A, Yang H, Rosario M, Røseth A, Danese S, Feagan B, Sands BE, Ginsburg P, Dassopoulos T, Lewis J, Xu J, Wyant T.

Inflamm Bowel Dis. 2019 Mar 14;25(4):803-810. doi: 10.1093/ibd/izy304.

4.

Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Johnson CM, Dassopoulos T.

Curr Gastroenterol Rep. 2018 Sep 28;20(11):53. doi: 10.1007/s11894-018-0658-1. Review.

PMID:
30267281
5.

Knowledge Gaps in the Management of Postoperative Crohn's Disease: A US National Survey.

Nguyen VQ, Mays JL, Lang M, Wu Y, Dassopoulos T, Regueiro M, Moss A, Proctor DD, Sorrentino D.

Dig Dis Sci. 2018 Jan;63(1):53-60. doi: 10.1007/s10620-017-4844-z. Epub 2017 Nov 17.

PMID:
29147878
6.

Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.

Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Dryden GW, Hanson JS, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kwon JH, Lazarev M, Li E, Mack D, Mannon P, Moulton DE, Newberry RD, Osuntokun BO, Patel AS, Saeed SA, Targan SR, Valentine JF, Wang MH, Zonca M, Rioux JD, Duerr RH, Silverberg MS, Cho JH, Hakonarson H, Zwick ME, McGovern DP, Kugathasan S.

Gastroenterology. 2017 Jan;152(1):206-217.e2. doi: 10.1053/j.gastro.2016.09.032. Epub 2016 Sep 28.

7.

Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.

Lee SD, Rubin DT, Sandborn WJ, Randall C, Younes Z, Schreiber S, Schwartz DA, Burakoff R, Binion D, Dassopoulos T, Arsenescu R, Gutierrez A, Scherl E, Kayhan C, Hasan I, Kosutic G, Spearman M, Sen D, Coarse J, Hanauer S.

Inflamm Bowel Dis. 2016 Aug;22(8):1870-80. doi: 10.1097/MIB.0000000000000805.

8.

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.

Sorrentino D, Marino M, Dassopoulos T, Zarifi D, Del Bianco T.

PLoS One. 2015 Dec 15;10(12):e0144900. doi: 10.1371/journal.pone.0144900. eCollection 2015.

9.

Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.

Huang C, Haritunians T, Okou DT, Cutler DJ, Zwick ME, Taylor KD, Datta LW, Maranville JC, Liu Z, Ellis S, Chopra P, Alexander JS, Baldassano RN, Cross RK, Dassopoulos T, Dhere TA, Duerr RH, Hanson JS, Hou JK, Hussain SZ, Isaacs KL, Kachelries KE, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kumar A, Kwon JH, Lazarev M, Mannon P, Moulton DE, Osuntokun BO, Patel A, Rioux JD, Rotter JI, Saeed S, Scherl EJ, Silverberg MS, Silverman A, Targan SR, Valentine JF, Wang MH, Simpson CL, Bridges SL, Kimberly RP, Rich SS, Cho JH, Rienzo AD, Kao LWH, McGovern DPB, Brant SR, Kugathasan S.

Gastroenterology. 2015 Nov;149(6):1575-1586. doi: 10.1053/j.gastro.2015.07.065. Epub 2015 Aug 14.

10.

Corrigendum: Impact of Retroflexion Vs. Second Forward View Examination of the Right Colon on Adenoma Detection: A Comparison Study.

Kushnir VM, Oh YS, Hollander T, Chen CH, Sayuk GS, Davidson N, Mullady D, Murad FM, Sharabash NM, Ruettgers E, Dassopoulos T, Easler JJ, Gyawali CP, Edmundowicz SA, Early DS.

Am J Gastroenterol. 2015 Jun;110(6):942. doi: 10.1038/ajg.2015.144. No abstract available.

PMID:
26052780
11.

Ulcerative Colitis Care Pathway.

Dassopoulos T, Cohen RD, Scherl EJ, Schwartz RM, Kosinski L, Regueiro MD.

Gastroenterology. 2015 Jul;149(1):238-45. doi: 10.1053/j.gastro.2015.05.036. Epub 2015 May 27. Review. No abstract available.

PMID:
26025078
12.

Impact of retroflexion vs. second forward view examination of the right colon on adenoma detection: a comparison study.

Kushnir VM, Oh YS, Hollander T, Chen CH, Sayuk GS, Davidson N, Mullady D, Murad FM, Sharabash NM, Ruettgers E, Dassopoulos T, Easler JJ, Gyawali CP, Edmundowicz SA, Early DS.

Am J Gastroenterol. 2015 Mar;110(3):415-22. doi: 10.1038/ajg.2015.21. Epub 2015 Mar 3. Erratum in: Am J Gastroenterol. 2015 Jun;110(6):942.

13.

Magnetic resonance enterography in the evaluation of Crohn's disease: a primer for the gastroenterologist.

Fowler KJ, Dassopoulos T, Raptis C.

Inflamm Bowel Dis. 2014 Nov;20(11):2179-88. doi: 10.1097/MIB.0000000000000132. Review.

PMID:
25054338
14.

A general framework for wireless capsule endoscopy study synopsis.

Zhao Q, Mullin GE, Meng MQ, Dassopoulos T, Kumar R.

Comput Med Imaging Graph. 2015 Apr;41:108-16. doi: 10.1016/j.compmedimag.2014.05.011. Epub 2014 Jun 10.

PMID:
24974010
15.

Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype.

Sorrentino D, Avellini C, Geraci M, Dassopoulos T, Zarifi D, Vadalaʼ di Prampero SF, Benevento G.

Inflamm Bowel Dis. 2014 Jun;20(6):1049-56. doi: 10.1097/MIB.0000000000000051.

PMID:
24788221
16.

Positioning therapy for Crohn's disease.

Gutierrez A, Dassopoulos T.

Curr Gastroenterol Rep. 2014;16(6):384. doi: 10.1007/s11894-014-0384-2. Review.

PMID:
24682780
17.

Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.

Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, Ciorba MA, Sayuk GS.

J Clin Gastroenterol. 2014 May-Jun;48(5):423-9. doi: 10.1097/MCG.0000000000000049.

18.

Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie.

Dassopoulos T, Sorrentino D.

Clin Gastroenterol Hepatol. 2014 May;12(5):818-20. doi: 10.1016/j.cgh.2013.12.006. Epub 2013 Dec 14. No abstract available.

PMID:
24342747
19.

American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.

Dassopoulos T, Sultan S, Falck-Ytter YT, Inadomi JM, Hanauer SB.

Gastroenterology. 2013 Dec;145(6):1464-78.e1-5. doi: 10.1053/j.gastro.2013.10.046. Review. No abstract available.

PMID:
24267475
20.

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Dassopoulos T, Dubinsky MC, Bentsen JL, Martin CF, Galanko JA, Seidman EG, Sandler RS, Hanauer SB.

Aliment Pharmacol Ther. 2014 Jan;39(2):163-75. doi: 10.1111/apt.12555. Epub 2013 Nov 17.

21.

Practical guide to understanding Comparative Effectiveness Research (CER).

Neely JG, Sharon JD, Graboyes EM, Paniello RC, Nussenbaum B, Grindler DJ, Dassopoulos T; Department of Otolaryngology-Head and Neck Surgery Washington School of Medicine, Saint Louis, Missouri.

Otolaryngol Head Neck Surg. 2013 Dec;149(6):804-12. doi: 10.1177/0194599813506539. Epub 2013 Oct 4.

PMID:
24098005
22.

Quality indicators for inflammatory bowel disease: development of process and outcome measures.

Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, Dassopoulos T, Denson LA, Dudley-Brown S, Garb A, Hanauer SB, Kappelman MD, Lewis JD, Lynch I, Moynihan A, Rubin DT, Sartor RB, Schwartz RM, Wolf DC, Ullman TA.

Inflamm Bowel Dis. 2013 Mar;19(3):662-8. doi: 10.1097/mib.0b013e31828278a2. Erratum in: Inflamm Bowel Dis. 2013 Aug;19(9):2040.

PMID:
23388547
23.

Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.

Chen CH, Kularatna G, Stone CD, Gutierrez AM, Dassopoulos T.

Ann Gastroenterol. 2013;26(3):189-190.

PMID:
24714228
24.

Host genes related to paneth cells and xenobiotic metabolism are associated with shifts in human ileum-associated microbial composition.

Zhang T, DeSimone RA, Jiao X, Rohlf FJ, Zhu W, Gong QQ, Hunt SR, Dassopoulos T, Newberry RD, Sodergren E, Weinstock G, Robertson CE, Frank DN, Li E.

PLoS One. 2012;7(6):e30044. doi: 10.1371/journal.pone.0030044. Epub 2012 Jun 13.

25.

An ileal Crohn's disease gene signature based on whole human genome expression profiles of disease unaffected ileal mucosal biopsies.

Zhang T, Song B, Zhu W, Xu X, Gong QQ, Morando C, Dassopoulos T, Newberry RD, Hunt SR, Li E.

PLoS One. 2012;7(5):e37139. doi: 10.1371/journal.pone.0037139. Epub 2012 May 14.

26.

Optimizing immunomodulators and anti-TNF agents in the therapy of Crohn disease.

Dassopoulos T, Sninsky CA.

Gastroenterol Clin North Am. 2012 Jun;41(2):393-409, ix. doi: 10.1016/j.gtc.2012.01.004. Review.

PMID:
22500525
27.

Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR.

Inflamm Bowel Dis. 2012 Dec;18(12):2277-87. doi: 10.1002/ibd.22931. Epub 2012 Mar 12.

28.

A decision fusion strategy for polyp detection in capsule endoscopy.

Zhao Q, Dassopoulos T, Mullin GE, Meng MQ, Kumar R.

Stud Health Technol Inform. 2012;173:559-65.

PMID:
22357058
29.

Towards integrating temporal information in capsule endoscopy image analysis.

Zhao Q, Dassopoulos T, Mullin G, Hager G, Meng MQ, Kumar R.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6627-30. doi: 10.1109/IEMBS.2011.6091634.

PMID:
22255858
30.

Assessment of Crohn's disease lesions in wireless capsule endoscopy images.

Kumar R, Zhao Q, Seshamani S, Mullin G, Hager G, Dassopoulos T.

IEEE Trans Biomed Eng. 2012 Feb;59(2):355-62. doi: 10.1109/TBME.2011.2172438. Epub 2011 Oct 18.

PMID:
22020661
31.

A meta method for image matching.

Seshamani S, Kumar R, Mullin G, Dassopoulos T, Hager GD.

IEEE Trans Med Imaging. 2011 Aug;30(8):1468-79. doi: 10.1109/TMI.2011.2119326. Epub 2011 Feb 24.

PMID:
21349789
32.

Thiopurine therapy in inflammatory bowel disease.

Ha C, Dassopoulos T.

Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59. Review.

PMID:
20932143
33.

Augmenting capsule endoscopy diagnosis: a similarity learning approach.

Seshamani S, Kumar R, Dassopoulos T, Mullin G, Hager G.

Med Image Comput Comput Assist Interv. 2010;13(Pt 2):454-62.

PMID:
20879347
34.

Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.

Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, Cheng Y, Jin Z, Yang J, Agarwal R, Abraham JM, Dassopoulos T, Harris M, Bayless TM, Kwon J, Harpaz N, Livak F, Meltzer SJ.

Inflamm Bowel Dis. 2011 Jan;17(1):221-31. doi: 10.1002/ibd.21359.

35.

Identification of microRNAs associated with ileal and colonic Crohn's disease.

Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH.

Inflamm Bowel Dis. 2010 Oct;16(10):1729-38. doi: 10.1002/ibd.21267.

36.

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T 3rd, McLeod R, Burgart LJ, Allen J, Brill JV; AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease.

Gastroenterology. 2010 Feb;138(2):738-45. doi: 10.1053/j.gastro.2009.12.037. No abstract available.

PMID:
20141808
37.

The development of clinical guidelines by the American Gastroenterological Association.

Dassopoulos T, Inadomi JM, Lewis JD, Allen JI.

Gastroenterology. 2010 Feb;138(2):417-8. doi: 10.1053/j.gastro.2009.12.028. Epub 2009 Dec 22. No abstract available. Erratum in: Gastroenterology. 2010 Mar;138(3):1215.

PMID:
20034602
38.

Common variants at five new loci associated with early-onset inflammatory bowel disease.

Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, Kugathasan S, Bradfield JP, Walters TD, Sleiman P, Kim CE, Muise A, Wang K, Glessner JT, Saeed S, Zhang H, Frackelton EC, Hou C, Flory JH, Otieno G, Chiavacci RM, Grundmeier R, Castro M, Latiano A, Dallapiccola B, Stempak J, Abrams DJ, Taylor K, McGovern D; Western Regional Alliance for Pediatric IBD, Silber G, Wrobel I, Quiros A; International IBD Genetics Consortium, Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmuda MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ; NIDDK IBD Genetics Consortium, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwillam R, Tremelling M, Delukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ, Heyman MB, Ferry GD, Kirschner B, Lee J, Essers J, Grand R, Stephens M, Levine A, Piccoli D, Van Limbergen J, Cucchiara S, Monos DS, Guthery SL, Denson L, Wilson DC, Grant SF, Daly M, Silverberg MS, Satsangi J, Hakonarson H.

Nat Genet. 2009 Dec;41(12):1335-40. doi: 10.1038/ng.489. Epub 2009 Nov 15.

39.

NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.

Dassopoulos T, Nguyen GC, Talor MV, Datta LW, Isaacs KL, Lewis JD, Gold MS, Valentine JF, Smoot DT, Harris ML, Oliva-Hemker M, Bayless TM; NIDDK IBD Genetics Consortium, Burek CL, Brant SR.

Am J Gastroenterol. 2010 Feb;105(2):378-86. doi: 10.1038/ajg.2009.575. Epub 2009 Oct 13.

40.

Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.

Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, Proctor D, Goyette P, Rioux J, Bitton A.

Am J Gastroenterol. 2009 Sep;104(9):2233-40. doi: 10.1038/ajg.2009.267. Epub 2009 Jun 9. Erratum in: Am J Gastroenterol. 2010 Oct;105(10):2308.

41.

Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis.

Nguyen GC, Frick KD, Dassopoulos T.

Gastrointest Endosc. 2009 Jun;69(7):1299-310. doi: 10.1016/j.gie.2008.08.042. Epub 2009 Feb 27.

PMID:
19249771
42.

A meta registration framework for lesion matching.

Seshamani S, Rajan P, Kumar R, Girgis H, Dassopoulos T, Mullin G, Hager G.

Med Image Comput Comput Assist Interv. 2009;12(Pt 1):582-9.

PMID:
20426035
43.

Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea.

Sullivan S, Alex P, Dassopoulos T, Zachos NC, Iacobuzio-Donahue C, Donowitz M, Brant SR, Cuffari C, Harris ML, Datta LW, Conklin L, Chen Y, Li X.

Inflamm Bowel Dis. 2009 Feb;15(2):261-74. doi: 10.1002/ibd.20743.

44.

MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH.

Gastroenterology. 2008 Nov;135(5):1624-1635.e24. doi: 10.1053/j.gastro.2008.07.068. Epub 2008 Aug 3.

PMID:
18835392
45.

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.

Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ; NIDDK IBD Genetics Consortium, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ.

Nat Genet. 2008 Aug;40(8):955-62. doi: 10.1038/ng.175. Epub 2008 Jun 29.

46.

Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004.

Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR.

Inflamm Bowel Dis. 2007 Dec;13(12):1529-35.

PMID:
17828784
47.

Rheostat regulation of integrin-mediated leukocyte adhesion.

Douglas IS, Dassopoulos T.

J Clin Invest. 2007 Sep;117(9):2391-5.

48.

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases.

De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, Vermeire S, Farwell L, Goris A, Libioulle C, Jani N, Dassopoulos T, Bromfield GP, Dubois B, Cho JH, Brant SR, Duerr RH, Yang H, Rotter JI, Silverberg MS, Steinhart AH, Daly MJ, Podolsky DK, Louis E, Hafler DA, Rioux JD; Quebec IBD Genetics Consortium; NIDDK IBD Genetics Consortium.

Genes Immun. 2007 Jul;8(5):387-97. Epub 2007 May 31.

49.

Pharmacogenomics of IBD Therapies.

Dassopoulos T.

Gastroenterol Hepatol (N Y). 2007 May;3(5):338-9. No abstract available.

50.

Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC).

Dassopoulos T, Nguyen GC, Bitton A, Bromfield GP, Schumm LP, Wu Y, Elkadri A, Regueiro M, Siemanowski B, Torres EA, Gregory FJ, Kane SV, Harrell LE, Franchimont D, Achkar JP, Griffiths A, Brant SR, Rioux JD, Taylor KD, Duerr RH, Silverberg MS, Cho JH, Steinhart AH.

Inflamm Bowel Dis. 2007 Aug;13(8):975-83.

PMID:
17427244

Supplemental Content

Loading ...
Support Center